Literature DB >> 7264813

Sustained-release theophylline for childhood asthma: evidence for circadian variation of theophylline pharmacokinetics.

P H Scott, E Tabachnik, S MacLeod, J Correia, C Newth, H Levison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7264813     DOI： 10.1016/s0022-3476(81)80354-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  27 in total

1.  [Circadian rhythms and clinical pharmacology].

Authors:  B Lemmer
Journal:  Internist (Berl)       Date:  2004-09       Impact factor: 0.743

2.  Allergy-important advances in clinical medicine: long-acting theophyllines.

Authors:  D L Marquardt
Journal:  West J Med       Date:  1984-10

Review 3.  [Chronopharmacology--significance for clinical treatment?].

Authors:  B Lemmer
Journal:  Klin Wochenschr       Date:  1989-09-15

4.  Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times.

Authors:  H Chrystyn; J W Ellis; B A Mulley; M D Peake
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

5.  The effect of dosing time on the pharmacokinetics and pharmacodynamics of a 'once-a-day' sustained release theophylline preparation.

Authors:  H Lamont; R Pauwels; M Van der Straeten
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

6.  A theophylline dosage regimen which reduces round-the-clock variations in plasma concentrations resulting from diurnal pharmacokinetic variation.

Authors:  M B Regazzi; R Rondanelli; E Vida; F Farinelli; R A Upton
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Acute and chronic pharmacokinetics of asymmetrical doses of slow release choline theophyllinate in asthma.

Authors:  S G Hibberd; C Alveyn; E J Coombes; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

Review 8.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

9.  Theophylline dosage adjustment during enoxacin coadministration.

Authors:  J R Koup; R D Toothaker; E Posvar; A J Sedman; W A Colburn
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

10.  Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.

Authors:  J H Jonkman; W J van der Boon; L P Balant; R Schoenmaker; A Holtkamp
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.